Atorvastatin Supplier-Buyer Network — Trade Flow Analysis

Name: Atorvastatin Supplier-Buyer Trade Network Dataset — 477+ Indian Exporters, 14+ Importers, 145+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Atorvastatin supplier network, Atorvastatin buyers, pharmaceutical export India, Atorvastatin trade data

TransData Nexus

Atorvastatin

India Pharmaceutical Trade Intelligence

$1.1B477 Suppliers145 CountriesHS 30049099

ExportsIndia → UNITED STATES52.5%India → CANADA25.9%

ImportsCROATIA → India$3.5M CANADA → India$2.5M

#1 Supplier: INTAS PHARMACEUTICALS #1 Buyer: APOTEX CORP

Who Supplies Atorvastatin? Top Manufacturers & Buyers 2026 — INTAS PHARMACEUTICALS LIMITED Leads | TransData Nexus | TransData Nexus

1INTAS PHARMACEUTICALS LIMITED

INTAS PHARMACEUTICALS LIMITED is the first-largest Atorvastatin exporter from India, with a market share of 24.3% and a total export value of $262.9M across 328 shipments. Their average shipment value of $801.6K is above the market average of $72.0K, suggesting premium or bulk contract pricing.

INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. BIOMEDPHARMA is the dominant customer, accounting for 73.8% of this supplier's tracked business. Top customers include:

• BIOMEDPHARMA — $194.1M across 242 shipments (73.8% of this supplier's total exports)

• ACCORD HEALTHCARE INC. — $57.6M across 72 shipments (21.9% of this supplier's total exports)

• ACCORD HEALTHCARE INC. — $9.7M across 12 shipments (3.7% of this supplier's total exports)

• ACCORD HEALTHCARE INC. — $1.2M across 2 shipments (0.5% of this supplier's total exports)

• TO THE ORDER — $345.8K across 0 shipments (0.1% of this supplier's total exports)

Key Insight: INTAS PHARMACEUTICALS LIMITED's per-shipment value of $801.6K is 1013% above the market average of $72.0K, consistent with large-order contracts or value-added formulations.

2PIRAMAL PHARMA LIMITED

PIRAMAL PHARMA LIMITED is the second-largest Atorvastatin exporter from India, with a market share of 20.8% and a total export value of $225.3M across 429 shipments. Their average shipment value of $525.1K is above the market average of $72.0K, suggesting premium or bulk contract pricing.

PIRAMAL PHARMA LIMITED serves 1 named buyer in our database. APOTEX CORP is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• APOTEX CORP — $225.3M across 429 shipments (100.0% of this supplier's total exports)

Key Insight: PIRAMAL PHARMA LIMITED's per-shipment value of $525.1K is 629% above the market average of $72.0K, consistent with large-order contracts or value-added formulations.

3MYLAN LABORATORIES LIMITED

MYLAN LABORATORIES LIMITED is the third-largest Atorvastatin exporter from India, with a market share of 13.6% and a total export value of $146.6M across 330 shipments. Their average shipment value of $444.2K is above the market average of $72.0K, suggesting premium or bulk contract pricing.

MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. MYLAN PHARMACEUTICALS INC is the dominant customer, accounting for 89.5% of this supplier's tracked business. Top customers include:

• MYLAN PHARMACEUTICALS INC — $131.2M across 295 shipments (89.5% of this supplier's total exports)

• MYLAN PHARMACEUTICALS INC — $11.0M across 25 shipments (7.5% of this supplier's total exports)

• MYLAN PHARMACEUTICALS INC — $1.7M across 4 shipments (1.2% of this supplier's total exports)

• MYLAN PHARMACEUTICALS INC — $1.4M across 3 shipments (1.0% of this supplier's total exports)

• XXlanXXrelXXd LXXite — $1.3M across 3 shipments (0.9% of this supplier's total exports)

Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $444.2K is 517% above the market average of $72.0K, consistent with large-order contracts or value-added formulations.

4MSN LABORATORIES PRIVATE LIMITED

MSN LABORATORIES PRIVATE LIMITED is the fourth-largest Atorvastatin exporter from India, with a market share of 5.0% and a total export value of $53.7M across 3.2K shipments. Their average shipment value of $16.6K is below the market average of $72.0K, reflecting a high-volume, competitive pricing strategy.

MSN LABORATORIES PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• TO THE ORDER OF — $19.6M across 1.2K shipments (36.5% of this supplier's total exports)

• NOVADOZ PHARMACEUTICALS LLC — $16.7M across 1.0K shipments (31.1% of this supplier's total exports)

• MSN LABORATORIES EUROPE LIMITED., — $9.5M across 568 shipments (17.6% of this supplier's total exports)

• MSN LABORATORIES EUROPE LIMITED., — $5.3M across 319 shipments (9.9% of this supplier's total exports)

• TO THE ORDER — $2.6M across 159 shipments (4.9% of this supplier's total exports)

Key Insight: MSN LABORATORIES PRIVATE LIMITED operates with high shipment frequency (3.2K shipments) at a per-shipment value of $16.6K, indicating a broad distribution network with many smaller, regular orders.

5UMEDICA LABORATORIES PRIVATE LIMITED

UMEDICA LABORATORIES PRIVATE LIMITED is the fifth-largest Atorvastatin exporter from India, with a market share of 3.4% and a total export value of $37.2M across 235 shipments. Their average shipment value of $158.4K is above the market average of $72.0K, suggesting premium or bulk contract pricing.

UMEDICA LABORATORIES PRIVATE LIMITED serves 5 named buyers in our database. LIFESCIENCE LOGISTICS is the dominant customer, accounting for 93.7% of this supplier's tracked business. Top customers include:

• LIFESCIENCE LOGISTICS — $34.9M across 220 shipments (93.7% of this supplier's total exports)

• CRESCENT PHARMA LTD — $927.9K across 6 shipments (2.5% of this supplier's total exports)

• CRESCENT PHARMA LIMI — $656.5K across 4 shipments (1.8% of this supplier's total exports)

• CRESCENT PHARMA LTD — $625.9K across 4 shipments (1.7% of this supplier's total exports)

• Life Science Logisti — $151.8K across 1 shipments (0.4% of this supplier's total exports)

Key Insight: UMEDICA LABORATORIES PRIVATE LIMITED's per-shipment value of $158.4K is 120% above the market average of $72.0K, consistent with large-order contracts or value-added formulations.

6ALKEM LABORATORIES LIMITED

ALKEM LABORATORIES LIMITED is the fifth-largest Atorvastatin exporter from India, with a market share of 3.3% and a total export value of $35.6M across 277 shipments. Their average shipment value of $128.6K is above the market average of $72.0K, suggesting premium or bulk contract pricing.

ALKEM LABORATORIES LIMITED serves 5 named buyers in our database. ASCEND LABOATORIES,LLC C/O UPS is the dominant customer, accounting for 78.5% of this supplier's tracked business. Top customers include:

• ASCEND LABOATORIES,LLC C/O UPS — $28.0M across 217 shipments (78.5% of this supplier's total exports)

• ASCEND LABORATORIES, — $3.3M across 26 shipments (9.3% of this supplier's total exports)

• ASCEND LABORATORIES, — $2.9M across 23 shipments (8.1% of this supplier's total exports)

• ASCEND LABORATORIES — $739.1K across 6 shipments (2.1% of this supplier's total exports)

• ASCEND LABORATORIES, — $702.8K across 5 shipments (2.0% of this supplier's total exports)

Key Insight: ALKEM LABORATORIES LIMITED's per-shipment value of $128.6K is 79% above the market average of $72.0K, consistent with large-order contracts or value-added formulations.

1United States

United States ranks as the first-largest destination for Atorvastatin imports from India, with a total trade value of $567.7M across 1,877 shipments — representing a 52.5% share of all Atorvastatin exports. The average shipment value of $302.4K is above the global average of $72.0K, indicating high-value procurement contracts or branded formulations. This market is served by 8 tracked buyers.

Named Atorvastatin importers in United States: APOTEX CORP is the largest buyer, accounting for 42.6% ($241.6M) of this market's total imports.

• APOTEX CORP — $241.6M (42.6% of United States's total)

• MYLAN PHARMACEUTICALS INC, — $136.0M (24.0% of United States's total)

• LIFESCIENCE LOGISTICS — $36.4M (6.4% of United States's total)

Key Insight: United States's per-shipment average of $302.4K (320% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Atorvastatin imports from India.

Primary Market

Secondary Market

2Canada

Canada ranks as the second-largest destination for Atorvastatin imports from India, with a total trade value of $279.4M across 141 shipments — representing a 25.9% share of all Atorvastatin exports. The average shipment value of $2.0M is above the global average of $72.0K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.

Named Atorvastatin importers in Canada: BIOMEDPHARMA is the largest buyer, accounting for 69.5% ($194.2M) of this market's total imports.

• BIOMEDPHARMA — $194.2M (69.5% of Canada's total)

• ACCORD HEALTHCARE INC., — $57.6M (20.6% of Canada's total)

• ACCORD HEALTHCARE INC. — $9.9M (3.6% of Canada's total)

Key Insight: Canada's per-shipment average of $2.0M (2651% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Canada is a key market for Atorvastatin imports from India.

Primary Market

Secondary Market

3Malta

Malta ranks as the third-largest destination for Atorvastatin imports from India, with a total trade value of $32.5M across 517 shipments — representing a 3.0% share of all Atorvastatin exports. The average shipment value of $62.8K is below the global average of $72.0K, consistent with generic/API volume purchasing. This market is served by 1 tracked buyer.

Named Atorvastatin importers in Malta: APL SWIFT SERVICES (MALTA) LTD., is the largest buyer, accounting for 84.9% ($27.6M) of this market's total imports.

• APL SWIFT SERVICES (MALTA) LTD., — $27.6M (84.9% of Malta's total)

Key Insight: Malta receives frequent, smaller shipments of Atorvastatin — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.

Malta is a key market for Atorvastatin imports from India.

Primary Market

Secondary Market

4United Kingdom

United Kingdom ranks as the fourth-largest destination for Atorvastatin imports from India, with a total trade value of $30.2M across 446 shipments — representing a 2.8% share of all Atorvastatin exports. The average shipment value of $67.7K is below the global average of $72.0K, consistent with generic/API volume purchasing. This market is served by 2 tracked buyers.

Named Atorvastatin importers in United Kingdom: MSN LABORATORIES EUROPE LIMITED is the largest buyer, accounting for 31.3% ($9.5M) of this market's total imports.

• MSN LABORATORIES EUROPE LIMITED — $9.5M (31.3% of United Kingdom's total)

• MSN LABORATORIES EUROPE LIMITED., — $5.3M (17.6% of United Kingdom's total)

Key Insight: United Kingdom receives frequent, smaller shipments of Atorvastatin — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.

United Kingdom is a key market for Atorvastatin imports from India.

Primary Market

Secondary Market

5Japan

Japan ranks as the fifth-largest destination for Atorvastatin imports from India, with a total trade value of $26.8M across 48 shipments — representing a 2.5% share of all Atorvastatin exports. The average shipment value of $557.6K is above the global average of $72.0K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Atorvastatin importers in Japan: SAWAI PHARMACEUTICAL CO.LTD. is the largest buyer, accounting for 24.4% ($6.5M) of this market's total imports.

• SAWAI PHARMACEUTICAL CO.LTD. — $6.5M (24.4% of Japan's total)

Key Insight: Japan's per-shipment average of $557.6K (674% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Japan is a key market for Atorvastatin imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Atorvastatin.
2.Flow Mapping: 477 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 15,000 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 145 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

15,000 Verified Shipments

477 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Atorvastatin

Atorvastatin

Who Supplies Atorvastatin? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Atorvastatin? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Atorvastatin Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1INTAS PHARMACEUTICALS LIMITED

2PIRAMAL PHARMA LIMITED

3MYLAN LABORATORIES LIMITED

4MSN LABORATORIES PRIVATE LIMITED

5UMEDICA LABORATORIES PRIVATE LIMITED

6ALKEM LABORATORIES LIMITED

From Indian Factories to Global Pharmacies — How Atorvastatin Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Atorvastatin Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Canada

3Malta

4United Kingdom

5Japan

People Also Ask — Atorvastatin Supplier & Trade Network

Atorvastatin Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology